The Stock Roach

Happy Humpday! Exit Only (Pink: EXTO) Is The Rally Over? Zoom technologies (ZOOM) technical update!

Senorita Roachita — Wed, 22 Feb 2012 13:15:28 +0000

Happy humpday mi amors!

As the oil sector rallied yesterday on worries over Iran and Greece, Exit only (Pink: EXTO) aka Bayport Corporation a well known stinky pinky holdings group with a strong focus on crude also benefited as the stock went on a tear from .006 to .009 before settling back down to close right at a former resistance and now tentative support level of .0075.

We covered EXTO back in Dec. at an all you could eat buffet of shares at an avg. price of .0055, so that’s a gain upwards of 80% in 2 months! So if you are one of the patient roaches that sat on a few shares of EXTO (and I know there’s quite a few of you lurking around) it’s almost like found money! Cha-ching!

EXTO coverage from Dec. http://www.stockroach.com/senoritas-humpday-special-is-exit-only-inc-pink-exto/

Does your Senorita think that the rally at EXTO can continue? Well, the charts say, “Yes it can.” and with buys outnumbering sells by almost 5:1 during yesterday’s trading, the chart is getting mucho caliente. There’s the beautiful MACD divergence starting, the RSI is in the trader “buy zone” of the 50s, the wick on the candle is a bit longer than I would prefer, but with EXTO a wick that long just shows me that those that have been holding for a few months might have just taken some off the table. Take a look at EXTO’s beautiful chart. http://stockcharts.com/h-sc/ui?s=EXTO&p=D&b=5&g=0&id=p01518581551

Support for EXTO comes in at .0075, with a lower level support of .006, and resistances lies ahead at .009, and .01.

Zoom technologies, inc. (Nasdaq: ZOOM) might be ready to go zoom, zoom, zoom and I will get to the techs after this REMINDER:

SIGN UP TODAY and start proudly calling yourself a Stockroach! Does everyone here remember the StockRoach motto? We do all the work, and YOU rake in the PROFITS! Click “Right Here” and then don’t forget you have to confirm the “activation” link in your email or you will just be wasting your time waiting for the next winner while the rest of us cash in. Once you confirm your FREE subscription you can also download your very own FREE copy of our e-Book, “A bottom feeder’s guide to surviving penny stocks.”

Don’t forget to join the thousands of other roaches on Twitter for intraday plays, and for heads up tweets when things get HOT at the StockRoach!

The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach

Zoom technologies, inc (Nasdaq: ZOOM) was my alert on Friday where there were plenty of shares at $1.30 – $1.32 and let me tell you my darlings that this puppy trades thin. 210K in volume ticks this sucker up a few pennies so I would like to see what it can do with some real volume. It appears that ZOOM will be tackling that $1.40 resistance sometime today. The techs from Friday are still in place.

Support for ZOOM comes in at $1.30 with a lower support level of $1.20, resistances lies ahead at $1.40, $1.50, and then it looks like it’s bluesky territory after $1.70.

For those that missed the ZOOM blog: http://www.stockroach.com/senorita-takes-a-look-at-zoom-technologies-inc-nasdaq-zoom-tech-updates-for-bpax-and-cbrx/

There’s a beautiful pincher on the MACD, and the buying volume is starting to get a bit heavier as well which is reflected in the RSI.

ZOOM chart: http://stockcharts.com/h-sc/ui?s=ZOOM&p=D&b=5&g=0&id=p71867454122

I’m really table pounding ZOOM guys and gals, and you know what happens when Senorita keeps pounding the table…..that’s right, the saavy roaches tend to rake it in while everyone ends up chasing at a higher PPS or misses out completely haha.

Senorita “Rockin’ Wall St.” Roachita

Disclosure: These corporate profiles are provided for information purposes only and should not be used as the basis for any investment decision. We are neither licensed nor qualified to provide investment advice. We were not paid, nor do we hold a position in these stocks. We reserve the right to buy or sell ZOOM and EXTO at any time after this post.

FROG captures Pam Anderson’s va-va-voom

Papa Roach — Tue, 21 Feb 2012 14:30:45 +0000

Traders Do The Jumping As Pammie Joins The FROG!

Happy Carnival, Roaches!

I’ve kept a close eye on FrogAds, Inc. (FROG) since the year started to let you know whenever conditions favored a big leap.

Every alert so far has put 10% to 30% in traders’ pockets, sometimes across two- or three-day rallies.

And I’m still waiting for FROG to hand you a much bigger score. The chart is definitely flashing with opportunity now, so let’s take a fresh look.

I like how FROG went a little crazy on Wednesday. Sudden swing up above the 20- and 100-day lines, MACD cross above signal, crazy stochastic action.

What happened, you ask? As you remember, FROG is like hippie-leaning Craigslist but with the pure profit motive of EBAY.

Running classified ads for everything from jobs to apartments to blind dates racked up roughly 29 million visitors a day and $115 million a year for Craigslist — they could have squeezed out more revenue, but FROG is not “above” that kind of profit motive. (Read more)

And adding auctions gives FROG a shot at a piece of EBAY’s $45 BILLION empire.

But to really earn the sweet green, FROG has to bring in the eyeballs…and as of last week, they’ve got the lovely and “enthusiastic” Pamela Anderson Lee to give them what William Shatner gave Priceline! (Read more)

That’s right. Pammie is now FROG’s celebrity spokesmodel.

The world’s skin-crazed nerds already run 2 MILLION online searches a month for “Pamela Anderson,” so FROG has a huge captive audience here. (Try it yourself)

Granted, about 900,000 of those clicks are probably from Papa Roach himself looking for Pammie’s “fundamentals,” but I’m apparently not alone.

Since scoring Pam, FROG has climbed 120% in the web traffic rankings! (Read more)

If that’s the growth story you’re looking for, FROG may be in position today to flex those golden legs and…well, just get it on your screen.Papa Roach

Jason Bond makes a killing on 3 simple trades each week ANYONE can follow. His real money verified trades are up 36% in the past 52 weeks. Learn how to profit from Jason.

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. StockRoach.com is a wholly-owned subsidiary of StockHideout, LLC. Bluewave Advisors LLC. owns seventy five percent of StockHideout LLC. BlueWave Advisors has been previously compensated one hundred and fifty thousand dollars from Lake Group Media (a non-affiliated third party) for FROG advertising and promotional services that have expired. Currently BlueWave Advisors has been compensated forty five thousand dollars from Lake Group Media (a non-affiliated third party) for FROG advertising and promotion. Stockhideout LLC has been compensated seven thousand five hundred dollars from BlueWave Advisors (a non-affiliated third party) for FROG advertising and promotion. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. StockHideout, LLC and its affiliates currently hold no shares in the profiled company. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Eat some Mardi Gras “cake” today!

Papa Roach — Tue, 21 Feb 2012 12:58:02 +0000

Good Morning, Trader!

Your batteries should be charged and fresh to take on today’s red hot alert.

It’s a stock that has the weight of headlines and hoopla behind it: an easy-to-explain business model in arguably the hottest sector of the year.

Management is keeping the market up to date on every little milestone, giving analysts plenty to ponder and traders all the catalysts you could ask for.

The last “little” milestone hit just last week, and it’s already created a huge impact in the company’s fundamental situation.

The news also lined up the chart in an all-new configuration!

Let’s just say that if this stock was making money before, its potential has just shifted into a gear we haven’t tested EVER.

It looks like racing gear, but only the morning will tell for sure…and as always, you won’t know either way unless you’re watching.

Papa Roach

Jason Bond makes a killing on 3 simple trades each week ANYONE can follow. His real money verified trades are up 36% in the past 52 weeks. Learn how to profit from Jason.

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. StockRoach.com is a wholly-owned subsidiary of StockHideout, LLC. Bluewave Advisors LLC. owns seventy five percent of StockHideout LLC. While BlueWave Advisors, LLC nor Stockhideout LLC has been compensated for the distribution of this particular email, any future email regarding a specific company will be the result of an advertising and promotional campaign for which BlueWave Advisors, LLC receives compensation. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. StockHideout, LLC and its affiliates currently hold no shares in the profiled company. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

This Trader has Found a Trick for Beating the Market

Papa Roach — Sun, 19 Feb 2012 23:15:23 +0000

Traders are Getting Rich Following SuperNova Stocks

Good Afternoon Trader!

With Monday being a market holiday, I wanted to take advantage of this time to remind you of a phenomenal opportunity that more than a thousand traders have already discovered to beat this market.

If you remember a short while ago, I tipped you off to one of the most profitable newsletters that traders just like yourself can get their hands on. Since that time the Nova newsletter has soared up the ranks and is currently ranked #1 out of 664 MEMBER reviewed newsletters according to an independently reviewed site — not to mention #1 in overall profit year to date according to another independent tracking system.

Since I told you about this cash cow, the SuperNova newsletter has posted over $400,000 worth of verified member profits in the past few months and GROWING!

As a matter of fact, their “Elite” level has an astonishing 87% success rate according to this 3rd party reviewer.

Hey listen, all I can say is this… I joined a few months ago and since that time my level of understanding AND my profits have skyrocketed from his list of services which include

Interactive webinars
Video lessons
Video watch lists
Educational library and my personal favorite…
Buy and sell text message alerts sent right to my smart phone

But don’t just listen to me….YOU be the judge!

Click on this link and decide for yourself which level you want to take your game to.

Here’s one last tip for you I found — if you are into saving money like I am, check out the “yearly” links under the sign up page which can save you up to 45% off which is like getting two years for one!

OK my friends, enjoy the break on Monday and I can’t wait to hear back from all of you that are serious about taking your trading to the next level with this incredible offer. I know it sure helped me!Papa Roach

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. StockRoach.com is a wholly-owned subsidiary of StockHideout, LLC. Bluewave Advisors LLC. owns seventy five percent of StockHideout LLC. While StockHideout, LLC has not been compensated for the distribution of this particular email any future email regarding a specific company will be the result of an advertising and promotional campaign for which StockHideout, LLC receives compensation. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. StockHideout, LLC and its affiliates currently hold no shares in the profiled company. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Senorita Takes A Look at Zoom Technologies, Inc. (Nasdaq: ZOOM). Tech Updates For BPAX And CBRX!

Senorita Roachita — Fri, 17 Feb 2012 13:31:43 +0000

TGIF mi amors!

Today your Senorita is taking a look at a stock that is in such a sizzling hot sector that I give a 5 jalapeno salute to this spicy enchilada! I am talking about Zoom technologies, inc. (Nasdaq: ZOOM) a company that has subsidiaries which manufacture and distribute the latest in mobile hardware technology, and is also a major distributor for T-Mobile USA.

With offices worlwide, this aint no stinky pinky that’s for sure. With revenue projections upwards of $400 million this year, which would be a $100 million INCREASE over last year’s $300 million, this is one you want to put onto your watchlists immediately! This puppy trades like a low floater, and it has shown quite a few times in the past to move over $100% in a matter of days with a little bit of volume and interest.

For all things ZOOM check out their very informative website! http://www.zoom.com/

Support for ZOOM comes in at $1.30 with a lower support level of $1.20, resistances lies ahead at $1.40, $1.50, and then it looks like it’s bluesky territory after $1.70.

Zoom has had quite a bit of accumulation in the $1.20-$1.30 ranges, and it looks like it wants to bounce right off of the RSI 50.

I’ll get to the BPAX and CBRX techs right after this REMINDER:

SIGN UP TODAY and start proudly calling yourself a Stockroach! Does everyone here remember the StockRoach motto? We do all the work, and YOU rake in the PROFITS! Click “Right Here” and then don’t forget you have to confirm the “activation” link in your email or you will just be wasting your time waiting for the next winner while the rest of us cash in. Once you confirm your FREE subscription you can also download your very own FREE copy of our e-Book, “A bottom feeder’s guide to surviving penny stocks.”

Don’t forget to follow us on Twitter for intraday plays, and for a heads up tweet when things get HOT at the StockRoach!

The StockRoach Twitter feed: http://twitter.com/#!/TheStockRoach

Let’s take a quick look at BioSante Pharmaceuticals (Nasdaq: BPAX) first and then I’ll get to CBRX. There’s been a lot of wondering about BPAX’s price and why it just can’t seem to stay over $1. Well with a rumored short count of 20 million or so, the bears are fighting back hard since they have more to lose. They are releasing their op-eds chock full of negativity and with bio-tech stocks being very news or should I say anal-yst sensitive it’s really no wonder that the price isn’t holding. My opinion is that the bears had a feeling that many would take profits upon the FDA giving the nod to Bio-T Gel and took advantage of the weakness in the share price as profit takers cashed out.

SAAVY ROACHES HAVE LOCKED IN BPAX GAINS UPWARDS OF 166% FROM MY ORIGINAL ALERT AT .45 SO FAR!

There has however been a strong accumulation of shares in the low to mid .80s, and it appears that the bulls will try and protect that .80 support region rather fiercly.

Support for BPAX comes in at .80, with a lower level support of .70. There was also a gap down in price, so their is a gap to be filled on the way up from .88 to $1.00.

Let’s finish this blog off with Columbia Laboratories (Nasdaq: CBRX) and just do a basic tech update on this FDA play with an NDA date from the FDA of Feb. 26th for their progesterone topical ointment Procheive, a joint venture with Watson Pharma (NYSE: WPI). So far CBRX IS UP 22% since MY ALERT AT .75!

Support for CBRX comes in at .80 with a lower level support at .75. Resistances lies ahead at .95, $1.00, and $1.10!

Check out my Valentine’s day blog for CBRX for more info on this fascinating bio-tech co.!

http://www.stockroach.com/its-fda-madness-biosante-pharmaceuticals-nasdaqbpax-and-columbia-laboratories-nasdaq-cbrx/

Senorita “It’s a Nasquack kinda day!” Roachita

Disclosure: These corporate profile are provided for information purposes only and should not be used as the basis for any investment decision. We are neither licensed nor qualified to provide investment advice. We were not paid, nor do we hold a position in these stocks. We reserve the right to buy or sell ZOOM, BPAX, CBRX and WPI at any time after this post.

Roaches, get ready to FLY!

Papa Roach — Fri, 17 Feb 2012 01:41:47 +0000

This Little Wonder Should Kick-Start Your Holiday Weekend!

Good Evening, Trader!

I know it’s a three-day weekend but keep that “trader” hat on tomorrow morning, because I’ve got another Friday Special on the menu and this one’s coming in HOT.

Yes! It’s been a big week around here — multiple alerts, multiple DOUBLE-DIGIT paydays — so let’s set off one more firecracker!

This company’s been around for decades and has a very high-end clientele. In fact, those world-class customers helped create the latest wave of products, so it’s a pretty good bet that they’re already “predisposed” to buy more.

Throughout that long time frame, traders who wanted exposure to this company’s unique story just couldn’t do it — shares weren’t available!

All that changed about 3 weeks ago. Suddenly, these shares were floating as free as any other under-a-dime stock and traders went berserk to get their piece of the action.

By my calculations, turnover here is up a healthy 500% in February alone, and the trend has been pointing toward the sky.

Something’s making traders jump over themselves for a shot at this ticker!
I won’t sleep until I find out. As for you, set your alarm and be ready to trade!

Papa Roach

Jason Bond makes a killing on 3 simple trades each week ANYONE can follow. His real money verified trades are up 36% in the past 52 weeks. Learn how to profit from Jason.

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. StockRoach.com is a wholly-owned subsidiary of StockHideout, LLC. Bluewave Advisors LLC. owns seventy five percent of StockHideout LLC. While BlueWave Advisors, LLC nor Stockhideout LLC has been compensated for the distribution of this particular email, any future email regarding a specific company will be the result of an advertising and promotional campaign for which BlueWave Advisors, LLC receives compensation. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. StockHideout, LLC and its affiliates currently hold no shares in the profiled company. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

BCDH is giving the Roach plenty “synergy”

Papa Roach — Thu, 16 Feb 2012 14:45:28 +0000

Good morning, Roachland!

Black Castle Developments Holding, Inc. (BCDH) is evolving into a real pint-sized conglomerate…and the “synergy” is already driving traders into a frenzy!

Take a look at those volume bars. Turnover is up 30 to 1 so far this month as BCDH makes good on its ambitions:

You’ll note that BCDH price action hasn’t exactly gone up 3,000% as yet.

Maybe this is one of those cases where “price FOLLOWS volume,” I don’t know.

What I do know is that up/down on BCDH shows 80% more buyers than sellers, mostly on that home run the stock hit last Wednesday.

After that, the trend lines are all crammed up around $0.06 to $0.09, so the right swing could easily break all the resistance points in one shot!

So what does BCDH do, Papa Roach?

Leading off with the sexiest of BCDH’s subsidiaries — a company called bizM3 — traders looking for a ground-floor chance to get into the white-hot mobile marketing industry will find it here. (Read more)

After all, sending marketing messages to mobile devices is what turned Groupon into a $10 BILLION dot-com empire.

I bet the guys who got into Groupon early are living easy now!

And the specific business opportunity BCDH is targeting here is already reckoned in the billions and DOUBLING every year! (Read more)

BCDH is already more than the sum of its parts

Now if that was all BCDH was about, it might be enough to get it in front of you.

But BCDH is also an business development incubator, which means management looks for acquisitions it can push together and generate more money off the sum of the parts.

Example: Now that BCDH has committed to buy bizM3, it’s steering the business toward hotels, restaurants, other “hospitality” customers. (Read more)

Meanwhile, BCDH just bought A-Shine, Inc., an established niche technology provider to the hospitality industry! (Read more)
Take A-Shine’s customers and feed them to bizM3′s sales team, and suddenly both businesses have a huge competitive edge.

That’s the kind of “synergy” traders are leaping into BCDH to capture for themselves!

And BCDH has a secret weapon!

BCDH had $800,000 in prime California residential property on its books in its last earnings statement — and that creates a solid base for future moves.

Billion-dollar upside potential…synergy…a portfolio of hard assets on the bottom.

That’s the BCDH proposition. Take a look this morning. Maybe the sizzle and the steak are on your menu?Papa Roach

Jason Bond makes a killing on 3 simple trades each week ANYONE can follow. His real money verified trades are up 36% in the past 52 weeks. Learn how to profit from Jason.

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. StockRoach.com is a wholly-owned subsidiary of StockHideout, LLC. Bluewave Advisors LLC. owns seventy five percent of StockHideout LLC. BlueWave Advisors has been compensated fifteen thousand dollars from Odd Marketing (a non-controlling third party shareholder) for BCDH advertising and promotion. Stockhdeout LLC has been compensated seven thousand five hundred dollars from BlueWave Advisors (a non-affiliated third party) for BCDH advertising and promotion. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. StockHideout, LLC and its affiliates currently hold no shares in the profiled company. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

HWIC is today’s Roach Alert

Papa Roach — Wed, 15 Feb 2012 14:30:51 +0000

Good morning!

You might remember HWIC Global, Inc. (HWIC) from the big 30% to 40% wins this “clean room” manufacturer earned us awhile back.

But while HWIC has made quite a few traders some handsome cash, its chart spent the last few months filling in the gaps.

But that was before Monday’s massive move put HWIC back on the market’s map!

See for yourself:

The entire market can read those lines perfectly well: HWIC is in play!

Fact is, traders were already intrigued at how HWIC kept signing massively lucrative contracts with the world’s leading hospitals, laboratories and manufacturers…at about $140 per square foot! (Read more)

That’s not exactly cheap, and these aren’t tiny closets we’re talking about, either, so HWIC is rolling in revenue on every deal that comes in.

Some of these facilities can get into the 10,000 square-foot range — that’s a 1/4 acre filled with hi-tech proprietary PVC walls, vents, power and HVAC, all included for maybe $1.4 MILLION. (Read more)

No wonder HWIC got to brag in its latest quarterly numbers that sales are up 80% on a year-over-year basis! (Read more)
HWIC has woken up…and is reaching for the sky!

But late last year, HWIC‘s normally “frisky” chart became an all-out battlefield as the shorts who controlled about 50% of the turnover ran into entrenched opposition and sent shares swinging 60% a day.

Now, according to FINRA filings, HWIC shorts have finally admitted defeat…and when I saw where the price action had come to rest, I knew I had to get this stock in front of you FAST!

You see, whenever HWIC has dipped to the $0.01 to $0.011 level in the recent past, these shares were trading back up at $0.024 to $0.03 the very next session!

Sure enough, HWIC got its first dose of 3-digit action in ages yesterday, a history-making move that broke all the way up above $0.05.

So where do we go from here? Keep an eye on HWIC this morning…and find out!Papa Roach

Jason Bond makes a killing on 3 simple trades each week ANYONE can follow. His real money verified trades are up 36% in the past 52 weeks. Learn how to profit from Jason.

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. StockRoach.com is a wholly-owned subsidiary of StockHideout, LLC. Bluewave Advisors LLC. owns seventy five percent of StockHideout LLC. BlueWave Advisors has been previously compensated sixty five thousand dollars from Indigo Advisors (a non-controlling third party shareholder) for HWIC advertising and promotional services that have expired. Currently BlueWave Advisors has been compensated forty thousand dollars from Indigo Advisors (a non-controlling third party shareholder) for HWIC advertising and promotion. In addition to previous payments disclosed above, we also expect to receive a total of one hundred thousand dollars in future compensation for this email advertisement and other marketing efforts related to HWIC from Ouisache Advisors (a non-controlling 3rd party). Stockhideout LLC has been compensated seven thousand five hundred dollars from BlueWave Advisors (a non-affiliated third party) for HWIC advertising and promotion. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. StockHideout, LLC and its affiliates currently hold no shares in the profiled company. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Calling all amigos to a favorite in “motion”

Papa Roach — Wed, 15 Feb 2012 03:36:00 +0000

Good Evening!

Listen up, because it’s going to get hot and heavy around here in the next few days.

Tomorrow’s alert is a niche player in some extremely high-growth markets, with some of the world’s most prestigious clients lined up for its products.
Under the right circumstances, the stock generated anywhere from 30% to over 100% a day for traders in the know.

But those “circumstances” just weren’t happening, leaving the price action in limbo…until yesterday.

Just 24 hours ago, lightning hit this stock and made it start paying out again.

Paying out BIG.

That’s when I knew I had to scamper to get this stock back in front of you.

Set the alarm and be ready for those bells to start ringing!

Papa Roach

Jason Bond makes a killing on 3 simple trades each week ANYONE can follow. His real money verified trades are up 36% in the past 52 weeks. Learn how to profit from Jason.

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. StockRoach.com is a wholly-owned subsidiary of StockHideout, LLC. Bluewave Advisors LLC. owns seventy five percent of StockHideout LLC. While BlueWave Advisors, LLC nor Stockhideout LLC has been compensated for the distribution of this particular email, any future email regarding a specific company will be the result of an advertising and promotional campaign for which BlueWave Advisors, LLC receives compensation. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. StockHideout, LLC and its affiliates currently hold no shares in the profiled company. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Teva, BioSante Win FDA Approval to Sell Men’s Testosterone-Replacement Gel

Senorita Roachita — Tue, 14 Feb 2012 22:22:54 +0000

Teva Pharmaceutical Industries Ltd. (TEVA)and BioSante Pharmaceuticals Inc. (BPAX) won U.S. clearance to sell Bio-T-Gel, a testosterone replacement therapy for men.

The Food and Drug Administration approved the transdermal gel, the agency said today in an e-mail. Teva, of Petach Tikva, Israel, will market Bio-T-Gel for men with low testosterone. The condition, known as hypogonadism, can cause erectile dysfunction, infertility, osteoporosis and muscle loss, according to the Mayo Clinic in Rochester, Minnesota.

BioSante, the original developer of Bio-T-Gel, estimates the market for male testosterone products is more than $1.2 billion in the U.S., where hypogonadism affects as many as 5 million men. BioSante, of Lincolnshire, Illinois, licensed the gel to Teva, the world’s largest generic-drug maker, and will receive milestone payments and royalties when the drug is commercialized.

Abbott Laboratories (ABT) won FDA approval in April for a testosterone product known as AndroGel and later sued Teva, alleging that Bio-T-Gel infringed the product’s patent. Abbott, of Abbott Park, Illinois, and Teva settled the litigation in December without disclosing the terms, BioSante said Jan. 31 in a statement.

BioSante’s other experimental testosterone product, LibiGel, is a topical treatment applied to the arm for female sexual dysfunction. The company fell 77 percent, the most in 12 years, on Dec. 15 after the drug failed to work better than a placebo in two trials. BioSante said Jan. 31 that it would decide within 90 days whether to continue studying LibiGel.

To contact the reporter on this story: Molly Peterson in Washington at mpeterson9@bloomberg.net

To contact the editor responsible for this story: Adriel Bettelheim at abettelheim@bloomberg.net

Disclosure: This corporate profile is provided for information purposes only and should not be used as the basis for any investment decision. We are neither licensed nor qualified to provide investment advice. We were not paid, nor do we hold a position in this stocks. We reserve the right to buy or sell BPAX at any time after this post.